These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8657340)

  • 1. [The physiopathology of acute spinal cord injury and a hope for a successful treatment].
    Harat M; Radek A; Kochanowski J
    Neurol Neurochir Pol; 1996; 30(1):123-35. PubMed ID: 8657340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology and treatment of spinal cord medulla injuries].
    Kochanowski J; Malara A; Chudzik W; Kaczorowska B
    Neurol Neurochir Pol; 1999; 32 Suppl 6():91-7. PubMed ID: 11107569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic strategies in the treatment of experimental spinal cord injury.
    Nockels R; Young W
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S211-7. PubMed ID: 1588610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological strategies in CNS trauma.
    Faden AI; Salzman S
    Trends Pharmacol Sci; 1992 Jan; 13(1):29-35. PubMed ID: 1311880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury.
    Faden AI
    Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute spinal cord injury, part II: contemporary pharmacotherapy.
    Dumont RJ; Verma S; Okonkwo DO; Hurlbert RJ; Boulos PT; Ellegala DB; Dumont AS
    Clin Neuropharmacol; 2001; 24(5):265-79. PubMed ID: 11586111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of central nervous system trauma.
    Faden AI
    Pharmacol Toxicol; 1996 Jan; 78(1):12-7. PubMed ID: 8685080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury.
    Amar AP; Levy ML
    Neurosurgery; 1999 May; 44(5):1027-39; discussion 1039-40. PubMed ID: 10232536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limiting spinal cord injury by pharmacological intervention.
    Priestley JV; Michael-Titus AT; Tetzlaff W
    Handb Clin Neurol; 2012; 109():463-84. PubMed ID: 23098731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
    Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
    Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and pharmacologic treatment of acute spinal cord injury.
    Kwon BK; Tetzlaff W; Grauer JN; Beiner J; Vaccaro AR
    Spine J; 2004; 4(4):451-64. PubMed ID: 15246307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury.
    Ates O; Cayli SR; Gurses I; Turkoz Y; Tarim O; Cakir CO; Kocak A
    J Clin Neurosci; 2007 Jul; 14(7):658-65. PubMed ID: 17532502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free radicals in CNS injury.
    Hall ED; Braughler JM
    Res Publ Assoc Res Nerv Ment Dis; 1993; 71():81-105. PubMed ID: 8380240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of glutamate receptor blockers on glutamate release following spinal cord injury. Lack of evidence for an ongoing feedback cascade of damage --> glutamate release --> damage --> glutamate release --> etc.
    McAdoo DJ; Hughes MG; Nie L; Shah B; Clifton C; Fullwood S; Hulsebosch CE
    Brain Res; 2005 Mar; 1038(1):92-9. PubMed ID: 15748877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bases for drug therapy of spinal cord injuries].
    Pointillart V; Petitjean ME; Senegas J
    Cah Anesthesiol; 1994; 42(4):517-20. PubMed ID: 7842321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection after spinal cord injury: state of the science.
    Segatore M; Way C
    SCI Nurs; 1997 Mar; 14(1):8-18. PubMed ID: 9165951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal cord injury. Review of basic and applied research.
    de la Torre JC
    Spine (Phila Pa 1976); 1981; 6(4):315-35. PubMed ID: 7025250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects.
    Tator CH
    Neurochirurgie; 1991; 37(5):291-302. PubMed ID: 1758561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of N-acetyl-cysteine and acetyl-L-carnitine on neural survival, neuroinflammation and regeneration following spinal cord injury.
    Karalija A; Novikova LN; Kingham PJ; Wiberg M; Novikov LN
    Neuroscience; 2014 Jun; 269():143-51. PubMed ID: 24680856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute stage of spinal injury (physiopathology). "Ischemic damage to the spinal cord"].
    Urciuoli R; Tommasino C
    Agressologie; 1993; 34 Spec No 2():63. PubMed ID: 7802142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.